Hovione Technology has partnered with Kiel University Institute of Pharmacy on methods of dry powder formulation for delivery of high doses of antibiotics using Hovione Technology TwinMax and 8Shot DPIs, the company said. Areas of exploration will include techniques such as the use of soft pellets and nanocrystals for formulation of drugs such as clarithromycin and … [Read more...] about Hovione Technology partners with Kiel University on dry powder formulations
Products and Services
Meggle signs deal for distribution of pharmaceutical grade lactose in the US
LBB Specialties announced that it has signed a strategic partnership deal with Meggle for distribution of Meggle's pharmaceutical lactose excipients, including lactose for inhalation formulations, in the United States through LBB's Charkit Chemical and American International Chemical (AIC) subsidiaries. Charkit Chemical President Jay Lang said that "representing … [Read more...] about Meggle signs deal for distribution of pharmaceutical grade lactose in the US
Adherium announces deal with Summatix
Inhaler monitoring company Adherium said that it has signed a deal with Summatix (formerly Charm Informatics) to allow data from Adherium's Hailie connected inhaler sensors to be accessed through the Summatix medical data platform. Adherium also announced the launch of a new Hailie app for patients and an updated platform for clinicians. Adherium received OTC … [Read more...] about Adherium announces deal with Summatix
Proveris Scientific adds to its Americas and Asia Pacific customer support team
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to its European customer support team. Mann, who most recently provided field support at TTP LabTech, joins Senior Field Service Engineer Kevin O'Keefe … [Read more...] about Proveris Scientific adds to its Americas and Asia Pacific customer support team
Merxin says FDA deems its MRX001 blister multidose DPI appropriate for generic Advair
According to generic inhalation device developer Merxin, the FDA has reviewed data for the company's MRX001 blister multidose DPI and suggested that the agency would accept the MRX001 as an AB rated substitutable version of Diskus. The company shared this quote from the FDA's response: “After reviewing your controlled correspondence submitted on May 3, 2019, the … [Read more...] about Merxin says FDA deems its MRX001 blister multidose DPI appropriate for generic Advair
Nemera acquires Insight Product Development
Device developer and manufacturer Nemera has announced its acquisition of Insight Product Development, which will become the US office of Nemera's “Insight Innovation Center.” The company's other design center office is located in La Verpillière, France. Insight's capabilities include early stage development of DPIs, MDIs, and connected devices. According to Nemera, … [Read more...] about Nemera acquires Insight Product Development
ISAB gets contract for nebulizer feasibility study
Inhalation Sciences (ISAB) has announced that "a leading European inhaled pharmaceutical developer" has contracted with the company for a feasibility study using ISAB's PreciseInhale aerosol generator with new nebulizer capabilities. The feasibility study is the first to use the nebulizer feature for the PreciseInhale system, which launched in February 2019, the … [Read more...] about ISAB gets contract for nebulizer feasibility study
One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza
The One Drop diabetes management platform has agreed to integrate MannKind’s BluHale inhaler monitoring device for the Afrezza insulin DPI, the companies said. The integration of the BluHale device will allow for monitoring of insulin doses, glucose forecasts, and other services for patients using the Afrezza inhaler. MannKind Corporation CEO Michael Castagna … [Read more...] about One Drop to integrate MannKind’s BluHale inhaler monitoring device for Afrezza
Iconovo announces positive results for ICOres study
DPI developer Iconovo has announced that a PK study of its ICOres reservoir-based inhaler demonstrated that the device delivered a budesonide/formoterol dry powder formulation as expected compared to Symbicort Turbuhaler. According to the company, the clinical study, which enrolled 29 healthy volunteers, showed "slightly higher values for ICOres" related to … [Read more...] about Iconovo announces positive results for ICOres study
Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy
Kurve Technology has announced that Seurat Therapeutics will use Kurve's intranasal delivery technology for Seurat's IGF-1 nasal aerosol for the treatment and prevention of migraines. Details of the development and collaboration agreement were not disclosed. In October 2018, Seurat announced that it had received a ~$510,000 grant from the National Institute of … [Read more...] about Seurat Therapeutics to use Kurve Technology device for intranasal migraine therapy